Man, X., Huang, J., Sun, S., Zhou, D., Zhang, B., Fang, S., . . . Li, H. (2024). Efficacy and safety of pyrotinib combined with albumin‐bound paclitaxel as first‐line treatment for HER2‐positive metastatic breast cancer in patients previously treated with adjuvant and/or neoadjuvant trastuzumab therapy. Clinical and Translational Medicine, 14(5), . https://doi.org/10.1002/ctm2.1687
Chicago-referens (17:e uppl.)Man, Xiaochu, et al. "Efficacy and Safety of Pyrotinib Combined with Albumin‐bound Paclitaxel as First‐line Treatment for HER2‐positive Metastatic Breast Cancer in Patients Previously Treated with Adjuvant And/or Neoadjuvant Trastuzumab Therapy." Clinical and Translational Medicine 14, no. 5 (2024). https://doi.org/10.1002/ctm2.1687.
MLA-referens (9:e uppl.)Man, Xiaochu, et al. "Efficacy and Safety of Pyrotinib Combined with Albumin‐bound Paclitaxel as First‐line Treatment for HER2‐positive Metastatic Breast Cancer in Patients Previously Treated with Adjuvant And/or Neoadjuvant Trastuzumab Therapy." Clinical and Translational Medicine, vol. 14, no. 5, 2024, https://doi.org/10.1002/ctm2.1687.
